, the primary ‘rescue’ meds are (generic) epoetin alpha (brand names Epogen, Procrit, Aransp), and
filgrastim (generic) (brand name Neupogen).
We do have a platelet booster here that has been approved for cancer treatment; it is generically known as oprelvekin (brand name Neumega), but its use has not been FDA approved for HCV treatment to my knowledge; it tends to worsen hemolytic anemia, although we have had a few patients in forum that have tried it.